HFPN Strategic Adviser Ed Harding discusses cardiovascular care with Health Europa Quarterly

News & Events

19 January 2022
AUTHOR: HFPN Admin

Ed Harding, Strategic Adviser to the Heart Failure Policy Network (HFPN), recently spoke with Health Europa Quarterly (HEQ) about the key challenges affecting the diagnosis, screening and treatment of heart failure.

In the interview, which is included in issue 20 of the HEQ online publication, Ed outlined how the HFPN was founded and its role in addressing gaps in heart failure care. The conversation also turned to learnings from the inaugural Heart Failure Policy Summit in 2021, which looked at heart failure in light of health inequalities, health system sustainability and the impact of COVID-19.

The key takeaway from the discussion is the need to increase knowledge and awareness of cardiovascular disease, and to make rapid improvements in European heart failure policy. ‘If you look at studies across Europe, we know that we are not very good at helping people who live with established cardiovascular disease,’ says Ed. ‘The message I would convey to anyone reading this article is that their government, or their region, should at least have a position, even if it’s not a strategy, on heart failure.’

Read the full article: https://www.healtheuropa.eu/connecting-care-for-cardiovascular-diseases/112819/

Tagged:

More from News & Events

Heart failure community meets in the European Parliament to
Heart failure community meets in the European Parliament to ...
11 December 2025
At this critical juncture, as the EU drafts its Cardiovascular Health Plan, the event brought together policymakers, clinicians, patient representatives and researchers from across...
Read article
New country profile highlights urgent need for national hear
New country profile highlights urgent need for national hear...
27 November 2025
Commissioned by the Netherlands Heart Institute as an addition to the existing 'Heart failure policy and practice in Europe' series, the profile is designed to equip advocates and ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.